The US Food and Drug Administration (FDA) has granted 510(k) clearance to the BioCharge Autobiologic Matrix, a bioresorbable synthetic implant developed by startup Atreon Orthopedics to enhance ...

Ottawa, April 07, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global bio-implants market size is predicted to increase from USD 147.66 billion in 2025 to approximately USD 271.47 billion ...

This systematic research has shown a growing interest in this biological treatment approach as augmentation procedure to favour integration of bone-graft, bone-graft substitutes, or bone implants ...

The OsteoPearl implant is a novel biological allograft implant designed to augment painful vertebral compression fractures by providing a natural bone scaffold for physiological fracture treatment.